Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer

Cellular Histone Modification Patterns Predict Prognosis and Treatment Response in Resectable Pancreatic Adenocarcinoma: Results From RTOG 9704

(2010) Ananya Manuyakorn et al.   JOURNAL OF CLINICAL ONCOLOGY

Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer

(2009) Grace M Callagy et al.   BMC CANCER

Associations between Selected Biomarkers and Prognosis in a Population-Based Pancreatic Cancer Tissue Microarray

(2009) M. Takikita et al.   CANCER RESEARCH

Clinicopathological Correlations of Cyclooxygenase-2, MDM2, and p53 Expressions in Surgically Resectable Pancreatic Invasive Ductal Adenocarcinoma

(2009) Marketa Hermanova et al.   PANCREAS

Molecular Control of Lymphatic Metastasis

(2008) Marc G. Achen et al.   Annals of the New York Academy of Sciences

Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer

(2008) James J. Farrell et al.   GASTROENTEROLOGY

Apoptotic pathways in pancreatic ductal adenocarcinoma

(2008) Rainer Hamacher et al.   Molecular Cancer

EGFR Antagonists in Cancer Treatment

(2008) Fortunato Ciardiello et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancer

(2008) Kai-Xing Ai et al.   WORLD JOURNAL OF GASTROENTEROLOGY